Senior Director / Vice President, Site Engagement & Awareness

This role is based in Cambridge, MA.

As Senior Director / Vice President of Precision Medicine Engagement and Awareness (PM E&A) you will define and implement all aspects of the clinical trial engagement and awareness for Relay Tx’s clinical-stage breast cancer program. You will be the leader of the PM E&A function and partner closely with internal and external stakeholders to develop solutions that drive awareness and enrollment of Relay Therapeutics breast cancer program, incorporate critical insights into medical strategy, and build external networks and partnerships to advance clinical trials and patient identification. We are seeking an individual who is an excellent communicator with strong interpersonal skills, who is a skilled relationship-builder and cross-functional collaborator, and actively engaged in the field of breast cancer.

Your Role:

• Plan, develop, and execute an integrated PM E&A strategy with internal and external stakeholders, KOL, clinical sites, patients for Relay Tx’s breast cancer program
• Establish and maintain credible scientific interactions with national and top regional opinion leaders as well as clinicians and researchers in breast cancer
• Serve as a subject matter expert for breast cancer and provide critical medical input into the development strategies of clinical programs
• Coach, develop, and retain a high performing team by creating and providing opportunities for learning and advancement
• Refine the PML/MSL strategy to drive patient/investigator identification and trial enrollment
• Provide leadership with congress planning and key opinion leader engagement including proactive facilitation of thought leader interactions, and comprehensive review and presentation of key insights and feedback
• Plan and conduct Medical Advisory boards in collaboration with external agencies to obtain critical feedback/input on Relay Tx’s breast cancer trial
• Lead development of indication/protocol level communication plans with external stakeholders and partners to drive trial awareness and referral for potential patients
• Advance our advocacy awareness and engagement strategy; partner with breast cancer advocacy groups to evaluate communication materials and raise awareness of Relay Tx clinical trials
  
  
  

Your Background:

• Health sciences advanced or doctoral degree, such as a PharmD, MD, or PhD highly preferred. PA, MSN, NP, DNP accompanied by previous pharmaceutical industry or clinical research experience in the area of breast cancer will be considered
• Clinical or prior pharmaceutical industry experience in therapeutic area of oncology is required
• 10+ years clinical or pharmaceutical experience with a minimum of 8 years of experience in field medical or clinical trial engagement and awareness roles
• Understanding of local medical practice and clinical decision making as it pertains to patient care
• Ability to interpret scientific data and translate this information to meet educational, clinical and research needs
• Understanding of the design and execution of research studies
• Exemplary communication and presentation skills
• Ability to think strategically and collaborate effectively
• Ability and willingness to travel
• Track record of successfully meeting or exceeding clinical trial timelines and patient recruitment goals
• History of building long-term relationships with investigative sites, advocacy groups and other key clinical research stakeholders
• Familiarity with effective digital clinical trials communication technologies
• Demonstrated expertise in CFR and GCP/ICH requirements and European Clinical Trial Directive
• This role is based in Cambridge, MA; No remote applicants please***
  
  
  

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process.

Our team is equal parts fearless and relentless, with a shared passion for working collaboratively in intellectually stimulating environments. If you’re excited by the challenge of putting protein motion at the heart of drug discovery and passionate about making a difference in the lives of patients, join us!